TY - JOUR T1 - Design and Estimation for the Population Prevalence of Infectious Diseases JF - medRxiv DO - 10.1101/2021.02.05.21251231 SP - 2021.02.05.21251231 AU - Eric J. Oh AU - Alyssa Mikytuck AU - Vicki Lancaster AU - Joshua Goldstein AU - Sallie Keller Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/02/08/2021.02.05.21251231.abstract N2 - Understanding the prevalence of infections in the population of interest is critical for making data-driven public health responses to infectious disease outbreaks. Accurate prevalence estimates, however, can be difficult to calculate due to a combination of low population prevalence, imperfect diagnostic tests, and limited testing resources. In addition, strategies based on convenience samples that target only symptomatic or high-risk individuals will yield biased estimates of the population prevalence. We present Bayesian multilevel regression and poststratification models that incorporate probability sampling designs, the sensitivity and specificity of a diagnostic test, and specimen pooling to obtain unbiased prevalence estimates. These models easily incorporate all available prior information and can yield reasonable inferences even with very low base rates and limited testing resources. We examine the performance of these models with an extensive numerical study that varies the sampling design, sample size, true prevalence, and pool size. We also demonstrate the relative robustness of the models to key prior distribution assumptions via sensitivity analyses.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported in part by the University of Virginia Strategic Investment Fund, award number SIF160 and in part by the Defense Threat Reduction Agency (DTRA) under Contract No. HDTRA1-19-D-0007.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Not applicable.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll simulated data and code to reproduce analyses are available at https://github.com/ericoh17/mrp_testing ER -